Clinical Trial Update: A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Subjects With Crohn's Disease [Phase 2, Phase 3]

View source ↗

Summary

This document reports the results of a Phase 2/3 trial evaluating adalimumab for maintenance of clinical remission in Japanese subjects with Crohn's disease. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Abbott | Conditions: Crohn's Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2010-06-09